What question did this study set out to answer?

This research aims to evaluate the cellular immune responses to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients.

March 26, 2026Open Access

Kinetics of cellular immune response to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients without infection

Key Points

This research aims to evaluate the cellular immune responses to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients.
Evaluated immune response kinetics post-vaccine boosters
Included participants from dialysis and kidney transplant groups
Monitored cellular immune responses over time
Patients exhibited limited cellular immune responses to vaccine boosters
Responses were variable among individuals
Findings suggest a need for improved vaccination strategies in high-risk groups

Abstract

Despite multiple vaccine boosters, dialysis and kidney transplant patients exhibited limited and variable cellular immune responses, highlighting the need for improved vaccination and monitoring strategies in these high-risk populations.

Kinetics of cellular immune response to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients without infection

Key Points

Abstract

Cite This Study

Also Consider

Also Consider